S Happe

Summary

Country: Germany

Publications

  1. ncbi request reprint [Primary central nervous system lymphoma as a neurological manifestation of AIDS stage]
    S Happe
    Klinik und Poliklinik fur Neurologie, Westfalische Wilhelms Universitat Munster, Albert Schweitzer Strasse 33, 48129 Munster
    Nervenarzt 72:136-42. 2001
  2. ncbi request reprint The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study
    S Happe
    Department of Neurology, University of Muenster, Germany
    J Neurol 248:1062-7. 2001
  3. ncbi request reprint Treatment of idiopathic restless legs syndrome (RLS) with gabapentin
    S Happe
    Department of Clinical Neurology, University of Vienna, Austria
    Neurology 57:1717-9. 2001
  4. ncbi request reprint [Sleep-related headaches]
    S Happe
    Klinik und Poliklinik fur Neurologie, Westfalische Wilhelms Universitat Munster, Bundesrepublik Deutschland
    Wien Klin Wochenschr 113:259-65. 2001
  5. ncbi request reprint Sleep disorders and depression in patients with Parkinson's disease
    S Happe
    Department of Neurology, University of Vienna, Austria
    Acta Neurol Scand 104:275-80. 2001
  6. ncbi request reprint Comorbidity of migraine and restless legs syndrome--a case-control study
    A M Rhode
    Department of Neurology, Klinikum Bremen Ost and University of Göttingen, Gottingen, Germany
    Cephalalgia 27:1255-60. 2007
  7. doi request reprint Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus
    G Moddel
    Department of Neurology, University of Munster, Albert Schweitzer Strasse 33, 48129 Munster, Germany
    J Neurol Neurosurg Psychiatry 80:689-92. 2009
  8. ncbi request reprint Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR)
    W H Oertel
    Department of Neurology, Center of Nervous Diseases, Philipps University Marburg, Rudolf Bultmann Str 8, D 35033 Marburg, Germany
    Neurology 67:1040-6. 2006
  9. ncbi request reprint Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep
    G G Tribl
    Department of Clinical Neurology, University of Vienna, Vienna General Hospital, Austria
    Nucl Med Commun 25:55-60. 2004
  10. ncbi request reprint Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
    Wolfgang H Oertel
    Department of Neurology, Philipps University, Rudolf Bultmann Strasse 8, D 35039 Marburg, Germany
    Sleep Med 9:228-39. 2008

Detail Information

Publications11

  1. ncbi request reprint [Primary central nervous system lymphoma as a neurological manifestation of AIDS stage]
    S Happe
    Klinik und Poliklinik fur Neurologie, Westfalische Wilhelms Universitat Munster, Albert Schweitzer Strasse 33, 48129 Munster
    Nervenarzt 72:136-42. 2001
    ..The main criteria for differential diagnosis from other secondary neuromanifestations such as cerebral toxoplasmosis, progressive multifocal leukoencephalopathy, abscesses, and infarctions are described...
  2. ncbi request reprint The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study
    S Happe
    Department of Neurology, University of Muenster, Germany
    J Neurol 248:1062-7. 2001
    ..The aim of this study was the evaluation of sleep disturbances and the quality of life (QoL) in PD patients with different dopaminergic treatment strategies...
  3. ncbi request reprint Treatment of idiopathic restless legs syndrome (RLS) with gabapentin
    S Happe
    Department of Clinical Neurology, University of Vienna, Austria
    Neurology 57:1717-9. 2001
    ..Polysomnographic data showed a reduction of periodic leg movements during sleep (PLMS) (p = 0.003) and PLMS index (p = 0.001). The authors conclude that gabapentin provides a well-tolerated and effective treatment of idiopathic RLS...
  4. ncbi request reprint [Sleep-related headaches]
    S Happe
    Klinik und Poliklinik fur Neurologie, Westfalische Wilhelms Universitat Munster, Bundesrepublik Deutschland
    Wien Klin Wochenschr 113:259-65. 2001
    ..Except for the latter, they were included in the International Classification of Sleep Disorders and are described in this article...
  5. ncbi request reprint Sleep disorders and depression in patients with Parkinson's disease
    S Happe
    Department of Neurology, University of Vienna, Austria
    Acta Neurol Scand 104:275-80. 2001
    ..The strong association of depression, disease severity and sleep disorders in PD patients underlines the importance of identifying and treating both conditions in these patients...
  6. ncbi request reprint Comorbidity of migraine and restless legs syndrome--a case-control study
    A M Rhode
    Department of Neurology, Klinikum Bremen Ost and University of Göttingen, Gottingen, Germany
    Cephalalgia 27:1255-60. 2007
    ..There is an association between RLS and migraine and, in addition, a co-association with depression. The underlying mechanism, however, remains undetermined and might be related to a dysfunction of dopaminergic metabolism in migraine...
  7. doi request reprint Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus
    G Moddel
    Department of Neurology, University of Munster, Albert Schweitzer Strasse 33, 48129 Munster, Germany
    J Neurol Neurosurg Psychiatry 80:689-92. 2009
    ..This study suggests that LEV-iv may be a safe and efficacious treatment of SE. Prospective and controlled trials are imperative to confirm these preliminary findings...
  8. ncbi request reprint Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR)
    W H Oertel
    Department of Neurology, Center of Nervous Diseases, Philipps University Marburg, Rudolf Bultmann Str 8, D 35033 Marburg, Germany
    Neurology 67:1040-6. 2006
    ..To assess the efficacy and safety of the dopamine agonist cabergoline in the treatment of patients with idiopathic restless legs syndrome (CATOR study)...
  9. ncbi request reprint Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep
    G G Tribl
    Department of Clinical Neurology, University of Vienna, Vienna General Hospital, Austria
    Nucl Med Commun 25:55-60. 2004
    ..Structures other than striatal D2 receptors are discussed as possible causes of the treatment effects in RLS...
  10. ncbi request reprint Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
    Wolfgang H Oertel
    Department of Neurology, Philipps University, Rudolf Bultmann Strasse 8, D 35039 Marburg, Germany
    Sleep Med 9:228-39. 2008
    ..In a pilot placebo-controlled study, low dosages of 0.5-2mg/24h rotigotine showed a dose-dependent beneficial effect in restless legs syndrome (RLS) patients...
  11. pmc Axonal polyneuropathy in obstructive sleep apnoea
    P Ludemann
    Department of Neurology, University of Munster, Albert Schweitzer Strasse 33, D 48129 Munster, Germany
    J Neurol Neurosurg Psychiatry 70:685-7. 2001
    ..It is assumed that recurrent intermittent hypoxaemia in OSA is an independent risk factor for axonal damage of peripheral nerves...